Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sheba Medical Center |
---|---|
Information provided by: | Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT00416143 |
sudden sensorineural hearing loss:
Condition | Intervention | Phase |
---|---|---|
Sudden Loss of Hearing |
Procedure: bed rest Drug: prednisone - oral corticosteroid 1mg/kg/D for 1 week |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss |
Ages Eligible for Study: | 16 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Eldar Carmel, MD | 972-3-5302442 | eldarca@sheba.health.gov.il |
Israel | |
Sheba Medical Center | Recruiting |
TEL HASHOMER, Israel | |
Contact: Eldar Carmel, MD 972-3-5302442 eldarca@sheba.health.gov.il | |
Principal Investigator: Eldar Carmel, MD |
Principal Investigator: | Eldar Carmel, MD | Sheba Medical Center |
Study ID Numbers: | SHEBA-06-4065-EC-CTIL |
Study First Received: | December 24, 2006 |
Last Updated: | December 24, 2006 |
ClinicalTrials.gov Identifier: | NCT00416143 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Bed rest for idiopathic sudden sensorineural hearing loss |
Prednisone Signs and Symptoms Sensation Disorders Hearing Disorders Deafness Otorhinolaryngologic Diseases |
Sensorineural hearing loss Hearing Loss, Sudden Neurologic Manifestations Hearing Loss, Sensorineural Hearing Loss Ear Diseases |
Nervous System Diseases |